Is Chronic Lyme Disease Real? A Medical Perspective

Persistent Lyme symptoms remain one of medicine’s most debated topics
Patients with chronic symptoms are often caught between competing frameworks
The chronic Lyme disease debate affects diagnosis, treatment, and recovery

I’ve treated patients with chronic Lyme disease symptoms for decades. During that time, I’ve watched the medical community remain deeply divided over one central question: Is chronic Lyme disease real?

Some physicians argue that once a standard course of antibiotics is completed, lingering symptoms must reflect immune dysfunction, residual inflammation, or unrelated illness rather than persistent infection.

Others believe Lyme disease may trigger ongoing or relapsing illness in at least a subset of patients.

The debate continues—but the suffering experienced by many patients is not theoretical.

For a broader discussion of persistent symptoms and recovery challenges, see Post-Treatment Lyme Disease Syndrome (PTLDS).

Why the Debate Exists

The controversy surrounding chronic Lyme disease is rooted partly in limitations of testing and partly in disagreements over how persistent symptoms should be interpreted.

Many physicians rely heavily on evidence-based treatment guidelines emphasizing short-course antibiotic therapy.

In that framework, ongoing symptoms after treatment are often attributed to:

• immune dysregulation
• inflammation after infection
• central sensitization
• unrelated chronic illness
• functional or psychiatric explanations

Others argue that persistent infection, immune activation, biofilms, persister cells, or coinfections may contribute to ongoing disease in some patients.

For many patients, the controversy itself becomes part of the illness experience.

What Patients Continue to Experience

Patients with chronic Lyme symptoms frequently report:

• fatigue
• brain fog
• neuropathy
• joint pain
• sleep disruption
• dizziness
• exercise intolerance
• autonomic dysfunction

These symptoms are often disabling and may persist long after initial treatment.

Many of these manifestations are increasingly recognized in medical literature, including:

• Neurologic Lyme disease
• Autonomic dysfunction and POTS
• Persistent Lyme symptoms
• Tick-borne coinfections
• PTLDS

A Shift Toward Acknowledging Persistent Symptoms

Over time, more physicians have acknowledged that some patients remain ill after Lyme disease treatment.

This growing recognition contributed to wider acceptance of PTLDS as a clinical entity.

Yet major disagreements remain.

Some experts view PTLDS as an immune-mediated post-infectious syndrome, while others continue investigating whether persistent infection or microbial remnants may contribute to ongoing illness.

This unresolved tension is central to the chronic Lyme disease controversy.

Why Definitions Matter

The terms chronic Lyme disease, persistent Lyme disease, and PTLDS are often used differently by physicians, researchers, and patients.

Some clinicians reserve the term PTLDS for persistent symptoms following standard treatment, while others use chronic Lyme disease more broadly to describe ongoing multisystem illness associated with Lyme disease.

These differences in terminology contribute significantly to the ongoing debate.

What Research Has Shown

Research continues to challenge earlier assumptions about Lyme disease.

Animal studies have demonstrated persistence of Borrelia burgdorferi after antibiotic exposure in some models.

Other studies have explored:

• persister cells
• biofilm formation
• immune dysregulation
• persistent inflammation
• coinfection burden

At the same time, researchers continue debating how these findings apply clinically to human disease.

Much remains uncertain.

Why Patients Often Feel Dismissed

Many patients report being told their symptoms are unrelated to Lyme disease despite persistent disability.

Others are diagnosed with anxiety, fibromyalgia, chronic fatigue syndrome, or functional disorders without a full reassessment of tick-borne illness history.

This contributes to feelings of abandonment and medical distrust.

For more on diagnostic complexity, see Delayed Lyme Disease Diagnosis.

The Importance of Clinical Open-Mindedness

Lyme disease remains a complex and evolving field.

Medicine advances by remaining open to new evidence—not by prematurely closing difficult questions.

The goal should not be ideological victory.

The goal should be understanding why some patients remain chronically ill and how best to help them recover.

Frequently Asked Questions

Is chronic Lyme disease real?

The existence and cause of chronic Lyme disease remain debated. However, persistent symptoms after Lyme disease are well documented.

What is PTLDS?

PTLDS stands for Post-Treatment Lyme Disease Syndrome, a condition involving persistent symptoms after standard Lyme disease treatment.

Can Lyme disease cause long-term neurologic symptoms?

Yes. Some patients experience ongoing cognitive, neurologic, autonomic, or neuropathic symptoms.

Why is chronic Lyme disease controversial?

The controversy centers on whether persistent symptoms reflect ongoing infection, immune dysfunction, inflammation, or other mechanisms.

Can coinfections complicate Lyme disease recovery?

Yes. Babesia, Bartonella, and other coinfections may contribute to persistent or overlapping symptoms.

Clinical Takeaway

Persistent symptoms after Lyme disease are increasingly recognized, even as debate continues regarding their underlying cause.

For patients living with chronic symptoms, the most important step is careful clinical evaluation, continued investigation, and an open-minded approach to recovery.

Related Articles

These related articles explore persistent symptoms, PTLDS, diagnostic controversy, and long-term Lyme disease complications.

Lyme Disease Misdiagnosis
Recovery From Lyme Disease
Chronic Lyme Disease Patients Dismissed by Medical Community
Lyme Disease Symptoms Guide
What Is Chronic Lyme Disease?

References

1. Baker PJ. Is It Possible to Make a Correct Diagnosis of Lyme Disease on Symptoms Alone? Review of Key Issues and Public Health Implications. Am J Med. 2019.
2. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990;323(21):1438-1444.
3. Fallon BA, Nields JA. Lyme disease: a neuropsychiatric illness. Am J Psychiatry. 1994;151(11):1571-1583.
4. Kanjwal K, Karabin B, Kanjwal Y, Grubb BP. Postural orthostatic tachycardia syndrome following Lyme disease. Cardiol J. 2011;18(1):63-66.
5. Krupp LB, Hyman LG, Grimson R, et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology. 2003;60(12):1923-1930.
6. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001;345(2):85-92.
7. Krause PJ, Telford SR 3rd, Spielman A, et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA. 1996;275(21):1657-1660.

---

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention